Michiel Bannier

614 total citations
23 papers, 279 citations indexed

About

Michiel Bannier is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Biomedical Engineering. According to data from OpenAlex, Michiel Bannier has authored 23 papers receiving a total of 279 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 6 papers in Physiology and 6 papers in Biomedical Engineering. Recurrent topics in Michiel Bannier's work include Cystic Fibrosis Research Advances (8 papers), Advanced Chemical Sensor Technologies (6 papers) and Asthma and respiratory diseases (6 papers). Michiel Bannier is often cited by papers focused on Cystic Fibrosis Research Advances (8 papers), Advanced Chemical Sensor Technologies (6 papers) and Asthma and respiratory diseases (6 papers). Michiel Bannier collaborates with scholars based in Netherlands, Germany and Belgium. Michiel Bannier's co-authors include Edward Dompeling, Quirijn Jöbsis, Kim D. G. van de Kant, Suzanne W. J. Terheggen‐Lagro, Eveline J. Langereis, Emilie P. Buddingh, Caroline L. H. Brackel, Marlies A. van Houten, Simone Hashimoto and C.J. Miedema and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Respiratory Journal and BMC Public Health.

In The Last Decade

Michiel Bannier

20 papers receiving 269 citations

Peers

Countries citing papers authored by Michiel Bannier

Since Specialization

Citations

This map shows the geographic impact of Michiel Bannier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michiel Bannier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michiel Bannier more than expected).

Fields of papers citing papers by Michiel Bannier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michiel Bannier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michiel Bannier. The network helps show where Michiel Bannier may publish in the future.

Co-authorship network of co-authors of Michiel Bannier

This figure shows the co-authorship network connecting the top 25 collaborators of Michiel Bannier. A scholar is included among the top collaborators of Michiel Bannier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michiel Bannier. Michiel Bannier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Introduction of Ivacaftor/Lumacaftor in Children With Cystic Fibrosis Homozygous for F508del in the Netherlands: A Nationwide Real‐Life Study 2025 ·Pediatric Pulmonology ·(unknown), (unknown), (unknown), Michiel Bannier, Hettie M. Janssens, Peter Merkus, Marianne Nuijsink, Suzanne W. J. Terheggen‐Lagro, Harm A.W.M. Tiddens, (unknown), Judith M. Vonk, Kate Groot, Brigitte W.M. Willemse, Gerard H. Koppelman	1
2	The Long-Term Uptake of Home Spirometry in Regular Cystic Fibrosis Care: Retrospective Multicenter Observational Study 2025 ·Journal of Medical Internet Research ·(unknown), (unknown), Michiel Bannier, Monique H. Reijers, Hester van der Vaart, Renske van der Meer, Josje Altenburg, (unknown), Bart L. Rottier, Marianne Nuijsink, (unknown), Peter Merkus, Jolt Roukema	0
3	Potential, Pitfalls, and Future Directions for Remote Monitoring of Chronic Respiratory Diseases: Multicenter Mixed Methods Study in Routine Cystic Fibrosis Care 2024 ·Journal of Medical Internet Research ·(unknown), (unknown), Michiel Bannier, Monique H. Reijers, Hester van der Vaart, Renske van der Meer, Josje Altenburg, (unknown), Bart L. Rottier, Marianne Nuijsink, (unknown), Peter Merkus, Maud Heinen, Jolt Roukema	5
4	Remote monitoring and teleconsultations can reduce greenhouse gas emissions while maintaining quality of care in cystic fibrosis 2024 ·Frontiers in Digital Health ·(unknown), Michiel Bannier, Monique H. Reijers, Hester van der Vaart, Renske van der Meer, Josje Altenburg, (unknown), Bart L. Rottier, Marianne Nuijsink, (unknown), Peter Merkus, Jolt Roukema	0
5	Accuracy, Reproducibility, and Responsiveness to Treatment of Home Spirometry in Cystic Fibrosis: Multicenter, Retrospective, Observational Study 2024 ·Journal of Medical Internet Research ·(unknown), Hanneke van Helvoort, Michiel Bannier, Monique H. Reijers, Hester van der Vaart, Renske van der Meer, Josje Altenburg, (unknown), Bart L. Rottier, Marianne Nuijsink, (unknown), Peter Merkus, Jolt Roukema	1
6	Successful treatment of a persistent air leak with an endobronchial valve in a 17‐year‐old patient with necrotizing pneumonia 2024 ·SHILAP Revista de lepidopterología ·(unknown), Rein Posthuma, (unknown), Michiel Bannier, Ulrich Lalji, Frits M.E. Franssen, Roy T.M. Sprooten	1
7	P067 Real-life data of lumacaftor/ivacaftor therapy in children with cystic fibrosis homozygous for F508del with emphasis on small airway disease in the Netherlands 2023 ·Journal of Cystic Fibrosis ·(unknown), (unknown), Michiel Bannier, Hettie M. Janssens, Peter Merkus, Marianne Nuijsink, Suzanne Terheggen‐Lagro, Harm A.W.M. Tiddens, (unknown), Domenique D. Zomer-van Ommen, (unknown), Gerard H. Koppelman	0
8	The ADEM2 project: early pathogenic mechanisms of preschool wheeze and a randomised controlled trial assessing the gain in health and cost-effectiveness by application of the breath test for the diagnosis of asthma in wheezing preschool children 2023 ·BMC Public Health ·(unknown), (unknown), Quirijn Jöbsis, Michiel Bannier, (unknown), Jan Damoiseaux, Onno C. P. van Schayck, Peter Merkus, Gerard H. Koppelman, Frederik‐Jan van Schooten, (unknown), (unknown), Agnieszka Smolinska, Edward Dompeling	2
9	COVID-19 in children and adolescents: MIS(-C)-taken diagnoses 2022 ·European Journal of Pediatrics ·(unknown), (unknown), Gertjan J. A. Driessen, Michiel Bannier	2
10	Long-term effectiveness of dual CFTR modulator treatment of cystic fibrosis 2022 ·ERJ Open Research ·Danya Muilwijk, Domenique D. Zomer-van Ommen, Vincent Gulmans, Marinus J.C. Eijkemans, Cornelis K. van der Ent, (unknown), Josje Altenburg, Suzanne W. J. Terheggen‐Lagro, (unknown), Karin M. de Winter‐de Groot, Marleen Bakker, Rogier A.S. Hoek, Hettie M. Janssens, Robert Van Der Meer, Marianne Nuijsink, C. H. van der Vaart, Gerard H. Koppelman, (unknown), Michiel Bannier, (unknown)	7
11	Epidemiology and management of nontuberculous mycobacterial disease in people with cystic fibrosis, the Netherlands 2022 ·Journal of Cystic Fibrosis ·Domenique D. Zomer-van Ommen, Jakko van Ingen, Regina W. Hofland, Onno W. Akkerman, Josje Altenburg, Marleen Bakker, Michiel Bannier, (unknown), Vincent Gulmans, Harry Heijerman, Rogier A.S. Hoek, Hettie M. Janssens, Renske van der Meer, Peter Merkus, (unknown), Marianne Nuijsink, Suzanne W. J. Terheggen‐Lagro, C. H. van der Vaart, Karin M. de Winter‐de Groot	3
12	Exhaled Breath Analysis for Investigating the Use of Inhaled Corticosteroids and Corticosteroid Responsiveness in Wheezing Preschool Children 2022 ·Journal of Clinical Medicine ·Michiel Bannier, (unknown), Quirijn Jöbsis, Kim D. G. van de Kant, Frederik‐Jan van Schooten, Agnieszka Smolinska, Edward Dompeling	2
13	Pediatric long‐COVID: An overlooked phenomenon? 2021 ·Pediatric Pulmonology ·Caroline L. H. Brackel, (unknown), Emilie P. Buddingh, Marlies A. van Houten, (unknown), Eveline J. Langereis, Michiel Bannier, (unknown), Simone Hashimoto, Suzanne W. J. Terheggen‐Lagro	103
14	The risk of community-acquired pneumonia in children using gastric acid suppressants 2021 ·European Respiratory Journal ·(unknown), Quirijn Jöbsis, Michiel Bannier, E.M.W. van de Garde, (unknown), Frank de Vries, Edward Dompeling, Johanna H. M. Driessen	11
15	Feasibility study on exhaled-breath analysis by untargeted Selected-Ion Flow-Tube Mass Spectrometry in children with cystic fibrosis, asthma, and healthy controls: Comparison of data pretreatment and classification techniques 2021 ·Talanta ·(unknown), (unknown), Johan Viaene, Michiel Bannier, Kim D. G. van de Kant, Edward Dompeling, Ann Van Eeckhaut, Joeri Vercammen, Yvan Vander Heyden	16
16	Discrepancy between Lung Function Measurements at Home and in the Hospital in Children with Asthma and CF 2020 ·Journal of Clinical Medicine ·(unknown), Quirijn Jöbsis, Michiel Bannier, Björn Winkens, Edward Dompeling	23
17	Exhaled Breath Condensate in Childhood Asthma: A Review and Current Perspective 2019 ·Frontiers in Pediatrics ·Michiel Bannier, Philippe Rosias, Quirijn Jöbsis, Edward Dompeling	16
18	Gut microbiota in wheezing preschool children and the development of childhood asthma 2019 ·Michiel Bannier, Liene Bervoets, Niels van Best, Quirijn Jöbsis, Edward Dompeling, John Penders	1
19	Feasibility and diagnostic accuracy of an electronic nose in children with asthma and cystic fibrosis 2018 ·Michiel Bannier, Kim van de Kant, Quirijn Jöbsis, Edward Dompeling	4
20	Hair tourniquet syndrome 2012 ·European Journal of Pediatrics ·Michiel Bannier, C.J. Miedema	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact